Senate Roll Call 103 - 2026: On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file)
- Roll Call Vote Number
- 103
- Topic
- On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file)
- Title
- Wyden Amdt. No. 5336
- Question
- On the Amendment
- Congress
- 119th Congress, Session 2
- Date
- Thursday, April 23, 2026, 2:51 AM
- Majority Required
- 1/2
- Result
- Amendment Rejected (48-50)
To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.
Yeas 48, Nays 50, Absent 2.
Vote Totals
| Yes | No | Not Voting | |
|---|---|---|---|
| Republican | 2 | 50 | 1 |
| Democrat | 44 | 0 | 1 |
| Independent | 2 | 0 | 0 |
| Total | 48 | 50 | 2 |
See how every member voted in the ReleVote app.